Compumedics Targets Double-Digit FY27 Growth After Record Sales
CMP: $0.235 +2.17% · MC: $48M
Compumedics reported record FY26 sales, up 18.5%, while EBITDA rose 74% and cash from operations increased from $0.4 million to $6.6 million. For FY27, it aims for double-digit sales growth and faster EBITDA growth, with over $28 million of orders to deliver; these are company objectives, not a forecast. At its AGM, shareholders re-elected Rod North and adopted the Remuneration Report.

Comments